Zynex downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital downgraded Zynex (ZYXI) to Sector Perform from Outperform with a price target of $5.50, down from $11. The firm says the company’s “disappointing update” on its Q4 earnings call suggests a lack of visibility into its operations and business outlook. Zynex called out slower than normal Q4 payments from certain payers and a notification by its largest payer, Tricare, of a temporary suspension of payments to review prior claims, the analyst tells investors in a research note. RBC cites the loss of the company’s largest payer and potential risk of a “domino effect” for the downgrade.